Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
07/05/2023 | Ambrx Biopharma Inc. | | Grant | Stock Option (right to buy) | 1.2M | $0.00 | $0 | | 07/05/2023 |
04/26/2023 | Ambrx Biopharma Inc. | | Grant | | 2.8M | $0.00 | $0 | | 04/26/2023 |
01/05/2023 | SEELOS THERAPEUTICS, INC. | APRI | Grant | Stock Option (right to buy) | 50k | $0.81 | $40.5k | | 01/05/2023 |
12/12/2022 | ZyVersa Therapeutics, Inc. | | Other (acquisition) | Common Stock | 1.4M | $0.00 | $0 | See Footnote | 12/12/2022 |
12/12/2022 | ZyVersa Therapeutics, Inc. | | Other (acquisition) | Series A Convertible Preferred Stock | 1.8k | $10.00 | $17.5k | | 12/12/2022 |
12/12/2022 | ZyVersa Therapeutics, Inc. | | Other (acquisition) | Warrant (right to buy) | 1.8k | $11.50 | $20.1k | | 12/12/2022 |
12/12/2022 | ZyVersa Therapeutics, Inc. | | Other (acquisition) | Warrant (right to buy) | 177.2k | $11.50 | $2M | See Footnote | 12/12/2022 |
06/01/2022 | SEELOS THERAPEUTICS, INC. | APRI | Purchase | Common Stock | 16k | $0.61 | $9.8k | | 06/01/2022 |
01/06/2022 | ZyVersa Therapeutics, Inc. | | Other (disposition) | | 23.4k | $0.00 | $0 | See Footnote | 01/06/2022 |
01/06/2022 | ZyVersa Therapeutics, Inc. | | Other (acquisition) | | 609 | $0.00 | $0 | See Footnote | 01/06/2022 |
01/06/2022 | ZyVersa Therapeutics, Inc. | | Other (acquisition) | | 42k | $0.00 | $0 | See Footnote | 01/06/2022 |
01/05/2022 | SEELOS THERAPEUTICS, INC. | APRI | Grant | Stock Option (right to buy) | 35k | $1.56 | $54.6k | | 01/05/2022 |
04/30/2021 | ONCOSEC MEDICAL Inc | ONCS | Sale | Common Stock | 3.2k | $4.86 | $15.4k | | 04/30/2021 |
02/01/2021 | ONCOSEC MEDICAL Inc | ONCS | Sale | Common Stock | 3.4k | $7.71 | $26.3k | | 01/31/2021 |
01/06/2021 | SEELOS THERAPEUTICS, INC. | APRI | Grant | Stock Option (right to buy) | 16k | $1.35 | $21.6k | | 01/06/2021 |
11/02/2020 | ONCOSEC MEDICAL Inc | ONCS | Sale | Common Stock | 3.3k | $3.79 | $12.4k | | 11/02/2020 |
08/24/2020 | ONCOSEC MEDICAL Inc | ONCS | Grant | Stock Option (Right to Buy) | 152k | $3.82 | $580.6k | | 08/24/2020 |
07/31/2020 | ONCOSEC MEDICAL Inc | ONCS | Sale | Common Stock | 3.1k | $4.20 | $13.2k | | 07/31/2020 |
05/29/2020 | ONCOSEC MEDICAL Inc | ONCS | Grant | Common Stock | 90.6k | $0.00 | $0 | | 05/29/2020 |
05/29/2020 | ONCOSEC MEDICAL Inc | ONCS | Payment of Exercise | Common Stock | 44.5k | $2.23 | $99.2k | | 05/29/2020 |
05/29/2020 | ONCOSEC MEDICAL Inc | ONCS | Grant | Stock Option (Right to Buy) | 304k | $1.56 | $474.2k | | 05/29/2020 |
04/30/2020 | ONCOSEC MEDICAL Inc | ONCS | Sale | Common Stock | 3.1k | $1.79 | $5.5k | | 04/30/2020 |
01/31/2020 | ONCOSEC MEDICAL Inc | ONCS | Sale | Common Stock | 2.7k | $1.96 | $5.2k | | 01/31/2020 |
01/06/2020 | SEELOS THERAPEUTICS, INC. | APRI | Grant | Stock Option (right to buy) | 16k | $1.42 | $22.7k | | 01/06/2020 |
10/31/2019 | ONCOSEC MEDICAL Inc | ONCS | Sale | Common Stock | 2.1k | $2.16 | $4.6k | | 10/31/2019 |
04/30/2019 | ONCOSEC MEDICAL Inc | ONCS | Payment of Exercise | Common Stock | 21.4k | $0.57 | $12.1k | | 04/30/2019 |
03/20/2019 | SEELOS THERAPEUTICS, INC. | APRI | Grant | Stock Option (right to buy) | 16k | $2.33 | $37.3k | | 03/20/2019 |
03/20/2019 | SEELOS THERAPEUTICS, INC. | APRI | Grant | Stock Option (right to buy) | 24k | $2.33 | $55.9k | | 03/20/2019 |
01/31/2019 | ONCOSEC MEDICAL Inc | ONCS | Payment of Exercise | Common Stock | 25.3k | $0.88 | $22.3k | | 01/31/2019 |
12/24/2018 | ONCOSEC MEDICAL Inc | ONCS | Grant | Common Stock | 750k | $0.00 | $0 | | 12/24/2018 |
11/07/2018 | ONCOSEC MEDICAL Inc | ONCS | Purchase | Common Stock | 10k | $0.91 | $9.1k | | 11/07/2018 |
05/03/2018 | ONCOSEC MEDICAL Inc | ONCS | Grant | Stock Option (Right to Buy) | 250k | $1.47 | $367.5k | | 05/03/2018 |
02/05/2018 | ONCOSEC MEDICAL Inc | ONCS | Purchase | Common Stock | 16.7k | $1.50 | $25k | | 02/05/2018 |
01/12/2018 | ONCOSEC MEDICAL Inc | ONCS | Grant | Stock Option (Right to Buy) | 500k | $0.00 | $0 | | 09/01/2017 |
01/12/2018 | ONCOSEC MEDICAL Inc | ONCS | Grant | Stock Option (Right to Buy) | 2M | $0.00 | $0 | | 09/01/2017 |
|